125 results
SC TO-I/A
EX-99
CYDY
CytoDyn Inc.
20 Jun 24
Issuer tender offer statement (amended)
3:16pm
of such sale, the subject of an investigation or proceeding to determine whether a stop order or suspension order should be issued?
(Please check one
SC TO-I
EX-99
CYDY
CytoDyn Inc.
3 Jun 24
Issuer tender offer statement
5:10pm
business, financial condition, or reputation. In addition, publicity surrounding any investigation, even if ultimately resolved in our favor, could
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:16pm
in the clinical development of leronlimab and is exploring potential business opportunities to continue the investigation of leronlimab for solid tumors
424B3
CYDY
CytoDyn Inc.
16 Apr 24
Prospectus supplement
5:15pm
in the clinical development of leronlimab and is exploring potential business opportunities to continue the investigation of leronlimab for solid tumors
424B3
cxtc3r76zhg3j3mf0zg
19 Jan 24
Prospectus supplement
5:15pm
424B3
bbm2ixg9
24 Oct 23
Prospectus supplement
6:01am
424B3
5muh56w7qlhxl fqvk8
10 Oct 23
Prospectus supplement
6:02pm
POS AM
av6xi
2 Oct 23
Prospectus update (post-effective amendment)
5:15pm
424B3
tq496shh4byi0rr
11 Jul 23
Prospectus supplement
5:28pm
8-K
EX-99.1
v17afcbl dfjlg
28 Oct 22
CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues
5:15pm